This compound is a quinazoline derivative used as an intermediate in pharmaceutical manufacturing. Its structure features a bromo-fluoro-substituted aniline group attached to a methoxyquinazolinol core.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 196603-96-0
3-Amino-4-chlorobenzamide
Pharmaceutical intermediate
Methyl 3-pyridin-3-yl-D-alaninate--hydrogen chloride (1/2)
Pharmaceutical intermediate for peptide synthesis
4-(3-Piperidyl)aniline Dihydrochloride
pharmaceutical intermediate
Dolutegravir impurity 3
reference standard for impurity analysis
Neptinib
active pharmaceutical ingredient
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide
active pharmaceutical ingredient
6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-quinazolinol
pharmaceutical intermediate for afatinib impurities
Erlotinib hydrochloride
active pharmaceutical ingredient
4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-ol
XIHOMGRMQWNHHB-UHFFFAOYSA-N
COC1=C(C=C2C(=C1)C(=NC=N2)NC3=C(C=C(C=C3)Br)F)O
—